112 related articles for article (PubMed ID: 6777839)
1. Effect of alpha-difluoromethyl ornithine on the transplantable rat hepatoma 5123, 1-1.
Kellen JA; Chan AW; Mirakian A
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):377-80. PubMed ID: 6777839
[TBL] [Abstract][Full Text] [Related]
2. [Ornithine decarboxylase activity in malignant tumors].
Siatkin SP; Berezov TT
Vopr Med Khim; 1980; 26(1):121-4. PubMed ID: 7368616
[TBL] [Abstract][Full Text] [Related]
3. [Antiproliferative activity of difluoromethylornithine and the factors decreasing its effectiveness in malignant growth].
Khomenko AK; Semeniĭ VIa; Gridina NIa; Diachok FI; Kudriavets IuI
Eksp Onkol; 1986; 8(3):61-4. PubMed ID: 3087732
[TBL] [Abstract][Full Text] [Related]
4. The role of alpha-difluoromethyl ornithine as an adjuvant to immunotherapy in mice bearing transplantable tumors.
Chowdhury SR; Guha S; Sen U
Neoplasma; 1994; 41(3):159-61. PubMed ID: 7935984
[TBL] [Abstract][Full Text] [Related]
5. [Ornithine decarboxylase and malignant growth].
Berezov TT
Biull Eksp Biol Med; 1993 Jun; 115(6):600-2. PubMed ID: 8374136
[TBL] [Abstract][Full Text] [Related]
6. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
[TBL] [Abstract][Full Text] [Related]
7. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
Bartholeyns J; Mamont P; Casara P
Cancer Res; 1984 Nov; 44(11):4972-7. PubMed ID: 6435861
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
9. Effect of calvatic acid and its analogs on ornithine decarboxylase activity in tumour cells.
Brossa O; Gadoni E; Olivero A; Seccia M; Miglietta A; Gabriel L; Gravela E
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):143-53. PubMed ID: 2277863
[TBL] [Abstract][Full Text] [Related]
10. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
11. Effect of catecholamines on ornithine decarboxylase activity monitored in the perfused rat heart.
Guarnieri C; Muscari C; Flamigni F; Caldarera CR
Ital J Biochem; 1983; 32(2):77-83. PubMed ID: 6414988
[TBL] [Abstract][Full Text] [Related]
12. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
13. [The effect of chemically modified polyamine analogs on polyamine and putrescine biosynthesis in a cell-free test system from a rat hepatoma].
Fedoronchuk TV; Siatkin SP; Lulle IZh; Ianson IaIa; Lidak MIu; Berezov TT
Biull Eksp Biol Med; 1993 Sep; 116(9):256-8. PubMed ID: 8117993
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
Sjoerdsma A; Golden JA; Schechter PJ; Barlow JL; Santi DV
Trans Assoc Am Physicians; 1984; 97():70-9. PubMed ID: 6442954
[No Abstract] [Full Text] [Related]
15. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
Bartholeyns J; Koch-Weser J
Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266
[TBL] [Abstract][Full Text] [Related]
16. Ornithine decarboxylase inhibitors and fetal growth retardation in mice.
Manen CA; Hood RD; Farina J
Teratology; 1983 Oct; 28(2):237-42. PubMed ID: 6648828
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of tilorone hydrochloride on a transplantable rat adenocarcinoma.
Kellen JA; Mirakian A
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):185-8. PubMed ID: 7291725
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of ornithine decarboxylase and c-met in growing Yoshida AH-130 hepatoma.
Desiderio MA; Limonta DM; Bardella L
Cancer Lett; 1994 Nov; 87(1):33-8. PubMed ID: 7954367
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
[TBL] [Abstract][Full Text] [Related]
20. [Rapid spectrophotometric method for determining ornithine decarboxylase using 2,4-dinitrofluorobenzene].
Siatkin SP; Berezov TT
Vopr Med Khim; 1980; 26(4):561-4. PubMed ID: 7456401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
